1. Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
   Fanxiang Yin et al, 2022, Acta Pharmaceutica Sinica B CrossRef
2. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology
   José C.J.M.D.S. Menezes et al, 2019, European Journal of Medicinal Chemistry CrossRef
3. Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones
   Samuel Legeay et al, 2020, International Journal of Molecular Sciences CrossRef
4. Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe
   Ariane S. Batista et al, 2022, Biomedicine & Pharmacotherapy CrossRef
5. Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones
   Violetta Krajka-Kuźniak et al, 2024, Cancers CrossRef
6. Recent therapeutic trends and promising targets in triple negative breast cancer
   Soo-Yeon Hwang et al, 2019, Pharmacology & Therapeutics CrossRef
7. The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
   Elizabeth Varghese et al, 2018, Cancers CrossRef
8. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation
   Xiang-xiang Jin et al, 2022, Phytomedicine CrossRef
9. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential
   Simon Mathien et al, 2021, Pharmacological Reviews CrossRef
10. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches
    Paola Pastena et al, 2024, International Journal of Molecular Sciences CrossRef
11. Chalcone Derivatives: Role in Anticancer Therapy
    Yang Ouyang et al, 2021, Biomolecules CrossRef
12. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
    Bahare Salehi et al, 2021, Frontiers in Pharmacology CrossRef
13. Small RNA proteome as disease biomarker: An incognito treasure of clinical utility
    Jyoti Roy et al, 2019, AGO-Driven Non-Coding RNAs CrossRef